| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.37 | 5e-14 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-12 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.28 | 6e-12 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-11 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.4 | 8e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-10 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-10 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-09 |